Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 181 AL 195

The CARE pathway model for dementia: psychosocial and rehabilitative strategies for care in young-onset dementias

Morhardt D, Weintraub S, Khayum B, Robinson J, Medina J, O'Hara M, Mesulam M, Rogalski EJ.

Psychiatr Clin North Am. 2015 Jun;38(2):333-52. doi: 10.1016/j.psc.2015.01.005. Epub 2015 Mar 7.

Effects of noninvasive brain stimulation on cognitive function in healthy aging and Alzheimer's disease: a systematic review and meta-analysis

Hsu WY, Ku Y, Zanto TP, Gazzaley A.

Neurobiol Aging. 2015 Aug;36(8):2348-59. doi: 10.1016/j.neurobiolaging.2015.04.016. Epub 2015 May 1.

The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease

Deardorff WJ, Feen E, Grossberg GT.

Drugs Aging. 2015 Jul;32(7):537-47. doi: 10.1007/s40266-015-0273-x.

The Effect of Memantine on Cognitive Function and Behavioral and Psychological Symptoms in Mild-to-Moderate Alzheimer's Disease Patients

Zhang N, Wei C, Du H, Shi FD, Cheng Y.

Dement Geriatr Cogn Disord. 2015;40(1-2):85-93. doi: 10.1159/000430808. Epub 2015 Jun 5.

Factors Associated with Greater Adherence to and Satisfaction with Transdermal Rivastigmine in Patients with Alzheimer's Disease and Their Caregivers

Riepe M, Weinman J, Osae-Larbi J, Mulick Cassidy A, Knox S, Chaves R, Müller B.

Dement Geriatr Cogn Disord. 2015;40(1-2):107-19. doi: 10.1159/000381894. Epub 2015 Jun 5.

Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials

Zis P, Mitsikostas DD.

J Neurol Sci. 2015 Aug 15;355(1-2):94-100. doi: 10.1016/j.jns.2015.05.029. Epub 2015 May 28.

Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial

Zhang Y, Lin C, Zhang L, Cui Y, Gu Y, Guo J, Wu D, Li Q, Song W.

PLoS One. 2015 Jun 15;10(6):e0130353. doi: 10.1371/journal.pone.0130353. eCollection 2015.

Alzheimer's Disease: Lessons Learned from Amyloidocentric Clinical Trials

Soejitno A, Tjan A, Purwata TE.

CNS Drugs. 2015 Jun;29(6):487-502. doi: 10.1007/s40263-015-0257-8.

Diagnosis and support for younger people with dementia

Hayo H.

Nurs Stand. 2015 Jul 22;29(47):36-40. doi: 10.7748/ns.29.47.36.e9197.

Namzaric--a combination of 2 old drugs for Alzheimer's disease

Med Lett Drugs Ther. 2015 Jul 20;57(1473):105-6.

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24.

Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease

Kalra J, Khan A.

Eur J Pharmacol. 2015 Oct 5;764:571-581. doi: 10.1016/j.ejphar.2015.07.043. Epub 2015 Jul 21.

[The scientific discourse about dementia in Germany-first results of the exemplary exercise of an integrative methodological approach]

Panke-Kochinke B, Krause G, Klimann O.

Pflege. 2015 Aug;28(4):219-32. doi: 10.1024/1012-5302/a000435.

What can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?

Becker RE, Seeman MV, Greig NH, Lahiri DK.

Lancet Psychiatry. 2015 Aug;2(8):756-764. doi: 10.1016/S2215-0366(15)00214-X.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias